INTRODUCTION
============

NAADP (nicotinic acid--adenine dinucleotide phosphate) is a potent Ca^2+^-mobilizing messenger, active in a wide variety of cells \[[@B1]--[@B4]\]. It is produced in response to a number of extracellular cues including hormones such as cholecystokinin \[[@B5]\] and neurotransmitters such as glutamate \[[@B6]\] (reviewed in \[[@B7]\]). NAADP-evoked Ca^2+^ signals have been implicated in many Ca^2+^-dependent processes ranging from fertilization \[[@B8],[@B9]\] to blood pressure control \[[@B10]\] (reviewed in \[[@B11]\]). Antagonizing NAADP action has recently been shown to reduce symptoms of autoimmune encephalomyelitis \[[@B12]\]. In a multitude of cells, NAADP appears to mobilize Ca^2+^ from acidic organelles \[[@B13]\], such as lysosomes \[[@B5]\], secretory vesicles \[[@B14]\] and endosomes \[[@B15]\], the so-called 'acidic Ca^2+^ stores' \[[@B16],[@B17]\]. These signals are often amplified by archetypal Ca^2+^ channels (inositol trisphosphate and ryanodine receptors) on the ER (endoplasmic reticulum) \[[@B18]\]. NAADP is thus thought to trigger complex Ca^2+^ signals \[[@B4]\]. However, other lines of evidence suggest that NAADP mobilizes Ca^2+^ from the ER through direct activation of ryanodine receptors \[[@B19],[@B20]\] or stimulates Ca^2+^ influx \[[@B21],[@B22]\]. Thus, despite its established physiological and likely patho-physiological importance, the molecular basis for Ca^2+^ release by NAADP is not entirely clear \[[@B23]\].

Of note are a series of reports from independent laboratories that have converged on the TPCs (two-pore channels) as likely NAADP targets responsible for the mobilization of Ca^2+^ from acidic organelles \[[@B24]--[@B26]\]. Three isoforms (TPC1--TPC3) are present in sea urchins \[[@B27],[@B28]\] (where the effects of NAADP were discovered \[[@B29]\]), but there has been striking lineage-specific loss of TPC3 in certain mammals, including humans \[[@B27],[@B30]\]. TPCs localize to the endolysosomal system and enhance NAADP-evoked Ca^2+^ signals when overexpressed \[[@B24]--[@B28],[@B31]--[@B33]\]. Knockdown of TPCs \[[@B24],[@B25],[@B33]\] or overexpression of TPCs harbouring a point mutation within the putative pore \[[@B24],[@B32],[@B33]\] inhibit endogenous NAADP responses. NAADP-evoked Ca^2+^ signals mediated by TPCs are amplified by ER Ca^2+^ channels \[[@B24],[@B25]\], but only when TPCs are correctly targeted to the endolysosomal system through an identified targeting motif \[[@B34]\]. Biophysical analyses indicate that TPCs are NAADP-gated Ca^2+^-permeable pore-forming subunits \[[@B34]--[@B36]\]. Physiological roles for TPCs have been confirmed in smooth muscle contraction \[[@B37]\], differentiation \[[@B38]\] and endothelial cell activation \[[@B39]\], processes in which NAADP-evoked Ca^2+^ signals had previously been implicated \[[@B10],[@B40],[@B41]\]. Additional unanticipated roles for TPCs have been identified in endolysosomal trafficking \[[@B28]\] and autophagy \[[@B32]\]. Thus multiple lines of evidence (reviewed in \[[@B7],[@B42]\]) point to this poorly characterized family of ion channels as the long sought NAADP target, important for Ca^2+^-dependent function.

At this early stage, little is known concerning the molecular architecture of TPCs. TPCs are members of the superfamily of voltage-gated ion channels \[[@B43]\]. They are structurally unusual in that they contain two homologous hydrophobic domains (I and II) each comprising six TM (transmembrane) regions and a pore ([Figure 1](#F1){ref-type="fig"}) connected by a cytosolic loop. This contrasts with voltage-sensitive K^+^ channels and TRP (transient receptor potential) channels which contain one such domain, and voltage-sensitive Na^+^/Ca^2+^ channels which contain four \[[@B43]\]. The basic topology of TPCs has recently been defined \[[@B44]\] using a combination of fluorescence protease protection assays, antibody epitope mapping and N-glycosylation analysis. In the present study, we address membrane insertion and oligomerization of TPCs.

![Dissecting the domain architecture of TPCs\
Top panel: schematic illustration of the TPC showing the two hydrophobic domains (I and II) each comprising six TM regions (numbered in domain I) and a pore (*P*). The domains are connected by a cytosolic loop. A summary of the constructs used in the present study encoding the indicated region, together with the predicted size of the Myc- and/or GFP-fusion proteins are listed in the bottom part of the Figure. Constructs correspond to human (TPC1 and TPC2) or sea urchin (SpTPC1--3) isoforms.](bic657i001){#F1}

MATERIALS AND METHODS
=====================

Plasmids
--------

Constructs (in pCS2+) encoding full-length human TPC1 and TPC2 tagged at their C-termini with five Myc tags (TPC1--Myc and TPC2--Myc) or GFP (green fluorescent protein; TPC1--GFP and TPC2--GFP) have been described previously \[[@B24],[@B45]\]. Constructs (also in pCS2+) encoding full-length sea urchin TPC1, TPC2 and TPC3 tagged at their C-termini with GFP (SpTPC1--GFP, SpTPC2--GFP and SpTPC3--GFP) have been described previously \[[@B27]\]. Constructs encoding C-terminally Myc-tagged human TPC1 fragments schematically depicted in [Figure 1](#F1){ref-type="fig"} were generated by PCR using IMAGE clone 40148827 (accession number BC150203) or pCS2+ TPC1 L273P, described in \[[@B24]\] for TPC1^226--347^, as a template. The primers used are listed in Supplementary Table S1 (at <http://www.BiochemJ.org/bj/441/bj4410317add.htm>). The products were digested with ClaI/EcoRI and ligated together with the EcoRI/XbaI fragment from pCS2+ TPC1--Myc (encompassing the five Myc tags) into the ClaI and XbaI sites of pCS2+. Constructs encoding C-terminally GFP-tagged TPC1 fragments were generated by cloning the ClaI/EcoRI-digested PCR products directly into the corresponding sites of pCS2+ TPC1--GFP \[[@B24]\]. A construct encoding C-terminally Myc-tagged domain I of TPC2 was generated by replacing the Xho and XbaI fragment of pCS2+ TPC2^1--339^--GFP (encoding the GFP tag) \[[@B44]\] with the corresponding region of pCS2+ TPC2--Myc harbouring the five Myc tags. Constructs encoding C-terminally Myc- and GFP-tagged domain II of TPC2 were generated by PCR using IMAGE clone 5214862 (accession number BC063008) as a template and the primers listed in Supplementary Table S1. The products were cloned into the EcoRI and XhoI sites of pCS2+ TPC2--Myc or pCS2+ TPC2--GFP. The coding sequences of all plasmids were fully sequenced.

Cell culture and transfection
-----------------------------

HEK (human embryonic kidney)-293 cells were cultured and plated as described previously \[[@B24]\]. They were transiently transfected with plasmids using Lipofectamine™ 2000 transfection reagent (Invitrogen) according to the manufacturer\'s instructions. Cells were harvested 1 day after transfection by scraping, washed once in PBS by centrifugation (500 ***g*** for 5 min) and resuspended in the indicated buffer (10 μl/cm^2^ adherent cells).

Subcellular fractionation
-------------------------

HEK-293 cells expressing the specified Myc-tagged constructs were resuspended in intracellular-like buffer composed of 110 mM potassium acetate, 2 mM MgCl~2~ and 20 mM sodium Hepes (pH 7.2). Samples (100 μl) were sonicated (1×5 s burst), centrifuged for 10 min at 4°C at 1000 ***g*** (to remove debris and nuclei) and the supernatant was recovered and diluted either in an equal volume of intracellular-like buffer or 0.2 M Na~2~CO~3~ (pH 11). Samples were incubated at 4°C for 60 min and centrifuged (90000 ***g*** for 60 min at 4°C). The supernatant was recovered and the resulting pellet was resuspended into the original volume of the appropriate buffer. Aliquots (typically 10 μl) were subject to SDS/PAGE followed by Western blot analysis.

Preparation of detergent-solubilized cell homogenates
-----------------------------------------------------

HEK-293 cells expressing the indicated Myc- and/or GFP-tagged construct(s) were resuspended in solubilization buffer comprising 20 mM Tris/HCl (pH 7.2), 50 mM NaCl, 10 mM magnesium acetate, 1% Triton X-100 (Pierce) and an EDTA-free protease inhibitor mixture (Roche). The suspension was rotated for 60 min at 4°C, centrifuged (90000 ***g*** for 60 min at 4°C) and the supernatant was recovered.

Co-immunoprecipitation
----------------------

Detergent-solubilized cell homogenates (200 μl) were incubated overnight at 4°C with 2.5 μg of anti-Myc antibody (9e10, Santa Cruz Biotechnology) on a rotator. The antibody was recovered by addition of Protein L-agarose-conjugated beads \[2.5% (v/v), Santa Cruz Biotechnology\] followed by incubation for 3 h at 4°C on a rotator. The beads were washed three times by centrifugation (60 s at 13000 ***g***) and resuspended in solubilization buffer (60 μl). The samples were then diluted with NuPAGE SDS sample buffer (Invitrogen) supplemented with 100 mM DTT (dithiothreitol). Elution was performed by incubating the beads at 50°C for 60 min followed by centrifugation (60 s at 13000 ***g***). Aliquots (typically 10 μl) were subject to SDS/PAGE followed by Western blot analysis.

Sucrose-density-gradient centrifugation
---------------------------------------

Detergent-solubilized cell homogenates (200 μl) were layered on to 1.8 ml 5--20% (w/v) sucrose density gradients (prepared in 3% increments in solubilization buffer) and centrifuged in a swing-out rotor at 166000 ***g*** for 3.5 h at 4°C. Fractions (195 μl) were collected from the top of the gradient and aliquots (20 μl) were subject to SDS/PAGE followed by Western blot analysis. Gradients were calibrated by analysing the distribution of the following standards (2 mg/ml) run in parallel and detected using the BCA protein assay: cytochrome *c* (12 kDa), alcohol dehydrogenase (150 kDa), β-amylase (200 kDa) and apoferritin (443 kDa).

Gel filtration
--------------

Detergent-solubilized cell homogenates (200 μl) were injected on to a Superdex 200 HR 10/30 column linked to an ÄKTA FPLC system (Amersham Biosciences) and equilibrated with solubilization buffer. Fractions (1 ml) were collected at a flow rate of 0.5 ml/min and concentrated by Microcon YM-10 centrifugal filter devices (Millipore) to \~60 μl. Equivalent volumes (typically 25 μl) were subjected to SDS/PAGE followed by Western blot analysis. The column was calibrated by analysing the elution of the following standards (10 mg/ml) detected by absorbance at 280 nm: alcohol dehydrogenase (150 kDa), β-amylase (200 kDa), apoferritin (443 kDa) and thyroglobulin (669 kDa).

Chemical cross-linking
----------------------

HEK-293 cells expressing the specified Myc- or GFP-tagged constructs were resuspended in PBS adjusted to pH 8, sonicated and samples (15 μg) were incubated with the indicated concentration of BS^3^ \[bis(sulfosuccinimidyl) suberate; Thermo Scientific\] in a total volume of 20 μl. Following incubation (10 min at 37°C), the pH of the samples was adjusted to 7.2 by addition of Tris. Aliquots (2 μg) were subject to SDS/PAGE followed by Western blot analysis.

Other methods
-------------

PNGase F (peptide N-glycosidase F) treatment, SDS/PAGE and Western blot analysis were performed as described previously \[[@B44]\]. Samples were separated using the NuPAGE system (Invitrogen). Both primary (anti-Myc or anti-GFP) and secondary horseradish-peroxidase-conjugated secondary antibodies were used at a 1:1000 dilution. Immunocytochemistry was also performed as described in \[[@B44]\] using Triton X-100-permeabilized cells, an anti-Myc primary antibody (1:100 dilution) and an Alexa Fluor® 568-conjugated secondary antibody (1:100 dilution), except that slides were stained with DAPI (4′,6-diamidino-2-phenylindole) prior to mounting.

RESULTS AND DISCUSSION
======================

To probe the assembly of TPCs, we analysed the 25 constructs schematically depicted in [Figure 1](#F1){ref-type="fig"}. All constructs were tagged at their C-termini with Myc tags or GFP (see the Materials and methods section). In the first set of experiments, we determined whether each hydrophobic domain of the TPC is capable of inserting into the membrane in isolation. To achieve this we performed Western blot analysis of membrane and soluble fractions prepared from cells expressing Myc-tagged domain I and II. We also analysed the connecting loop. As shown in [Figure 2](#F2){ref-type="fig"}(A), domain I of TPC1 (encoded by TPC1^1--347^--Myc) readily inserted into the membrane since the majority of the expressed protein appeared in the pellet fraction upon high-speed centrifugation. Essentially similar results were obtained using cells expressing domain II encoded by TPC1^427--816^--Myc ([Figure 2](#F2){ref-type="fig"}A). Notably, multiple bands were observed for domain II in pellet fractions that were sensitive to PNGase F, which removes carbohydrate residues from asparagine (Supplementary Figure S1A at <http://www.BiochemJ.org/bj/441/bj4410317add.htm>). These results indicate that domain II is N-glycosylated, as reported previously for full-length TPC1 \[[@B44]\]. Since N-glycosylation occurs within the luminal environment, these data provide further evidence for membrane insertion of domain II. Domain I and domain II of TPC2 encoded by TPC2^1--339^ and TPC2^422--752^ respectively were also found to readily insert into the membrane ([Figure 2](#F2){ref-type="fig"}B). Similar to TPC1, domain II of TPC2 migrated as a heterogeneous population ([Figure 2](#F2){ref-type="fig"}B). In contrast, the connecting loop of TPC1 encoded by TPC1^348--426^--Myc was recovered in the supernatant fraction ([Figure 2](#F2){ref-type="fig"}A). These data, summarized in [Figures 2](#F2){ref-type="fig"}(C) and [2](#F2){ref-type="fig"}(D), indicate that each hydrophobic domain is capable of independently inserting into the membrane. Accordingly, immunocytochemical analysis of domain I and II of TPC1 showed a non-uniform perinuclear distribution, whereas the connecting loop was distributed evenly throughout the cytosol (Supplementary Figure S1B).

![Membrane insertion of TPC domains\
(**A** and **B**) Western blot analysis, using an anti-Myc antibody, of pellet (P) and supernatant (S) fractions prepared from cells expressing the indicated region of TPC1 (**A**) and TPC2 (**B**). The molecular mass in kDa is indicated on the left-hand side. Summary data quantifying the distribution of the expressed protein is shown in (**C**) (*n*\>3) and (**D**) (*n*=2). DI, domain I; DII, domain II.](bic657i002){#F2}

To determine how the individual hydrophobic domains of TPCs insert into the membrane, we focused on domain I of TPC1. We analysed constructs encoding the first two TM regions (TPC1^1--166^--Myc), TM regions 3 and 4 (TPC1^167--225^--Myc) and TM regions 5 and 6 (TPC1^226--347^--Myc; [Figure 1](#F1){ref-type="fig"}). Fractionation experiments similar to those described above revealed that a significant proportion of each construct was recovered in the pellet fraction ([Figure 3](#F3){ref-type="fig"}A). These data suggest that TM regions 1, 3 and 5 all possess signal anchor activity, consistent with sequential co-translational integration of each TM region typical of other polytopic membrane proteins \[[@B46]\]. We noted, however, that insertion of TM 1 and 2 was less efficient than the other TM region pairs (summarized in [Figure 3](#F3){ref-type="fig"}C). To further investigate this, we performed experiments where cell homogenates were incubated in the presence of Na~2~CO~3~ prior to fractionation. This treatment strips membranes of loosely associated proteins that fail to fully integrate into the membrane. As shown in [Figure 3](#F3){ref-type="fig"}(B), Na~2~CO~3~ treatment had a modest effect on insertion of TM 3 and 4 and TM 5 and 6. Thus after treatment the majority of the protein was retained within the membrane (summarized in [Figure 3](#F3){ref-type="fig"}D). However, a majority of TM 1 and 2 was recovered in the supernatant fraction in the presence of Na~2~CO~3~ ([Figures 3](#F3){ref-type="fig"}B and [3](#F3){ref-type="fig"}D). These data further suggest that integration of the first two TM regions is inefficient. We note the presence of charged residues in TM regions 1 and 2 of both TPC1 and TPC2 ([Figure 3](#F3){ref-type="fig"}E) which may inhibit translocation of the nascent polypeptide chain, as reported previously for cystic fibrosis transmembrane conductance regulator \[[@B47]\]. Alternatively, the TM regions may require stabilization by other regions within the domain. In voltage-gated K^+^ channels, negatively charged residues in the second TM region interact with positively charged residues in the fourth TM region to promote channel maturation \[[@B48]--[@B50]\]. Thus biogenesis of TPCs might proceed by both co- and 'post'-translational insertion of TM regions.

![Membrane insertion of TM pairs\
Western blot analysis, using an anti-Myc antibody, of pellet (P) and supernatant (S) fractions prepared from cells expressing the indicated pair of TM regions within domain I of TPC1. Fractionation was performed in the absence (**A**) or presence (**B**) of 0.1 M Na~2~CO~3~. The molecular mass in kDa is indicated on the left-hand side. (**C** and **D**) Summary data quantifying the distribution of the expressed protein (*n*\>3). (**E**) Sequence alignment of TM regions 1 and 2 of TPC1 and TPC2 highlighting the presence of conserved charged residues (indicated by \*).](bic657i003){#F3}

Previous studies have shown co-immunoprecipitation of heterologously expressed Myc- and GFP-tagged mouse TPC2 \[[@B26]\], indicating that TPCs probably form oligomers. Similar results were obtained with Myc- and GFP-tagged human TPC1 and TPC2 (results not shown). To identify the molecular determinants of the interaction, we analysed extracts from cells co-expressing GFP and Myc-tagged fragments of TPC1 and TPC2. When cell extracts expressing GFP- and Myc-tagged domain I were immunoprecipitated with an anti-Myc antibody and the immunopreciptates were probed with an anti-GFP antibody, we detected the presence of domain I--GFP (TPC1^1--347^--GFP) by Western blot analysis ([Figure 4](#F4){ref-type="fig"}A). These results indicate that domain I alone is capable of oligomerization. Domain II, which we showed above to insert independently into membranes, was also capable of oligomerization as evidenced by the co-immunoprecipitation of TPC1^427--816^--GFP and TPC1^427--816^--Myc ([Figure 4](#F4){ref-type="fig"}A). Similar experiments using control IgG in place of the Myc antibody during immunoprecipitation failed to reveal an interaction (results not shown). GFP-tagged domain I and II of TPC2 (TPC2^1--339^--GFP and TPC2^422--752^--GFP) were also found to co-immunoprecipitate with the corresponding Myc-tagged construct ([Figure 4](#F4){ref-type="fig"}A). In contrast, we detected only a weak interaction between Myc and GFP (TPC1^348--426^--GFP)-tagged constructs encoding the connecting loop of TPC1 ([Figure 4](#F4){ref-type="fig"}A), attesting to specificity. This was despite similar expression levels of all constructs ([Figure 4](#F4){ref-type="fig"}A). These data indicate that both hydrophobic domains contribute to oligomerization in the channel complex.

![Oligomerization of TPCs\
(**A**) Top panels: Western blot analysis using an anti-GFP antibody of immunoprecipitates prepared using an anti-Myc antibody from cells co-expressing GFP- and Myc-tagged domain I (DI), loop (L) or domain II (DII) of the indicated isoform. Western blot analysis using an anti-GFP or anti-Myc antibody of the detergent extracts prior to immunoprecipitation are shown in the middle and bottom panels respectively. (**B**) Western blot analysis using an anti-GFP antibody of immunoprecipitates prepared using an anti-Myc antibody from cells co-expressing the indicated GFP- and Myc-tagged TM regions of TPC1. Data are representative of 2--11 experiments. The molecular mass in kDa is indicated on the left-hand side. IB, immunoblot; IP, immunoprecipitation.](bic657i004){#F4}

To further define interacting regions within TPCs, we again focused on domain I of TPC1. Ancestral voltage-gated ion channels were probable oligomeric complexes formed by subunits resembling TM regions 5 and 6, similar to extant K^+^ leak channels \[[@B43]\]. We therefore analysed Myc- and GFP-tagged constructs corresponding to the first four TM regions (TPC1^1--225^) and TM regions 5 and 6 (TPC1^226--347^) of domain I ([Figure 1](#F1){ref-type="fig"}). Co-immunoprecipitation experiments showed that Myc- and GFP-tagged TM 1--4 interacted ([Figure 4](#F4){ref-type="fig"}B). These data indicate that TM regions 5 and 6 are not necessary for oligomerization of domain I. However, Myc- and GFP-tagged TM 5 and 6 also co-immunoprecipitated ([Figure 4](#F4){ref-type="fig"}B). Similar results were obtained with TM 1 and 2 and TM 3 and 4 ([Figure 4](#F4){ref-type="fig"}B). Thus any pair of TM regions within the first domain is capable of interaction. There is therefore marked redundancy at both the intra- and inter-domain levels in the molecular determinants that govern oligomerization of TPCs.

Given that TPCs correspond to essentially one half of voltage-sensitive Ca^2+^ and Na^+^ channels, TPCs are likely to form dimers. To gain insight into the domain architecture of the TPC complex we performed cross-linking of the individual hydrophobic domains using the lysine-reactive reagent BS^3^. Western blot analysis of cell extracts expressing GFP-tagged domain I of TPC1 showed that BS^3^-induced a clear concentration-dependent accumulation of protein that had a molecular mass approximately twice that in the absence of cross-linker ([Table 1](#T1){ref-type="table"}). Similar results were obtained using cell extracts expressing GFP-tagged domain II of TPC1 ([Figure 5](#F5){ref-type="fig"}A and [Table 1](#T1){ref-type="table"}). These results suggest that individual domains can form dimers. Evidence for dimer formation upon cross-linking was also obtained for domain I and domain II of TPC2 ([Figure 5](#F5){ref-type="fig"}B and [Table 1](#T1){ref-type="table"}). We noted the presence of domain dimers in the absence of cross-linker. Intriguingly this was isoform-specific, observable only for domain II of TPC1 and domain I of TPC2, and particularly notable for the latter. These data are suggestive of differences in the molecular make-up of TPC1 and TPC2.

###### Summary of domain cross-linking experiments

The size of the monomeric and dimeric sized bands and the ratio (dimer/monomer) is shown for each domain construct analysed. Results are means±S.E.M. from *n* experiments.

  Isoform   Domain      Construct             Monomeric size (kDa)   Dimeric size (kDa)   Ratio      *n*
  --------- ----------- --------------------- ---------------------- -------------------- ---------- -----
  TPC1      Domain I    TPC1^1--347^--GFP     66±1                   138±4                2.1±0.07   7
  TPC1      Domain II   TPC1^427--816^--GFP   70±1                   156±5                2.2±0.06   4
  TPC2      Domain I    TPC2^1--339^--GFP     54±2                   125±2                2.3±0.07   3
  TPC2      Domain II   TPC2^422--752^--GFP   57±2                   126±2                2.2±0.05   3

![Cross-linking of TPCs\
(**A**--**C**) Western blot analysis of GFP-tagged hydrophobic domains of TPC1 (**A**), TPC2 (**B**) or the indicated TM regions of TPC1 (**C**). Experiments were performed in the presence of the indicated concentration (in mM) of BS^3^. The presence of monomeric (M), dimeric (D), tetrameric (T) or high-molecular-mass (H) products are highlighted by the arrows. The molecular mass in kDa is indicated on the left-hand side. (**D**) Schematic diagram showing the conservation of the four-domain (squares) architecture between tetrameric one-domain channels (e.g. K~v~), dimeric two-domain channels (TPC) and monomeric four-domain channels (e.g. Ca~v~). In TPCs, the central pore is likely to be formed by contacts between all four domains within the dimer (shaded regions), whereas regions outside the pore may form contacts with only one neighbouring domain (hatched regions).](bic657i005){#F5}

It is notable that no tetrameric species were observed in the above experiments, given the tetrameric assembly of one-domain channels such as K^+^ channels and TRP channels to which the TPC domains analysed in the present study are analogous. To investigate this further, we performed cross-linking of the first four TM regions (TPC1^1--225^), and TM regions 5 and 6 (TPC1^226--347^) of TPC1. As shown in [Figure 5](#F5){ref-type="fig"}(C), TPC1 TM 1--4 formed dimers in the presence of cross-linker similar to domain I. In contrast, TM 5 and 6 formed both dimers and tetramers ([Figure 5](#F5){ref-type="fig"}C). These data suggest a 'dimer of dimers' arrangement of the first four TM regions where contacts are formed with only one adjacent domain within the full-length dimer of TPCs. In contrast, the central pore is probably formed by interaction between all four pore loops in TM regions 5 and 6 (two from each subunit) ([Figure 5](#F5){ref-type="fig"}D). Results of cross-linking, gel filtration and sucrose-density-gradient centrifugation of full-length TPCs in order to determine native size were equivocal. Thus whereas high molecular mass complexes (\>400 kDa) were observed upon cross-linking and gel filtration, TPCs appeared much lighter (\~150 kDa) on sucrose density gradients (Supplementary Figure S2 at <http://www.BiochemJ.org/bj/441/bj4410317add.htm>). Anomalous migration of TPCs is consistent with anomalous migration of endogenous NAADP receptors (detected by radioligand binding) in sea urchin eggs \[[@B51]\].

To conclude, we show that each hydrophobic domain of TPCs is capable of insertion and forming oligomers, probably reflective of the ancestral one-repeat channel from which it evolved. Between TM pairs within a domain, we identify co-operativity during insertion and redundancy during oligomerization. We also present evidence that TPCs probably form dimers involving differential interactions between and within individual domains. The results of the present study provide the first insight into the biogenesis of the TPCs.

AUTHOR CONTRIBUTION
===================

Dev Churamani and Robert Hooper designed, performed and analysed experiments. Eugen Brailoiu assisted in the design of experiments. Sandip Patel directed the project and wrote the paper.

ACKNOWLEDGEMENT
===============

We thank Chi Li for useful discussions.

FUNDING
=======

This work was supported by the Biotechnology and Biological Sciences Research Council \[grant number BB/G013721/1\].

[^1]: ^1^These authors contributed equally to this work.
